Clinical significance of the sparteine/debrisoquine oxidation polymorphism K. BrøsenL. F. Gram Special Articles Pages: 537 - 547
Criteria for the choice and definition of healthy volunteers and or patients for phase I and phase II studies in drug development P. R. BechtelG. Alvan Special Articles Pages: 549 - 550
Relevance of genetic polymorphism in drug metabolism in the development of new drugs L. P. BalantU. Gundert-RemyCh. von Bahr Originals Pages: 551 - 554
Sparteine oxidation polymorphism: phenotyping by measurement of sparteine and its dehydrometabolites in plasma W. D. PaarH. SchuhlerH. J. Dengler Originals Pages: 555 - 560
Effects of diltiazem and isosorbide-5-mononitrate, alone and in combination, on patients with stable angina pectoris H. EmanuelssonH. ÅkeR. Arina Originals Pages: 561 - 566
Acute calcium entry blockade inhibits the blood pressure but not the hormonal responses to angiotensin II J. StaessenR. FagardA. Amery Originals Pages: 567 - 573
Renal and hormonal effects of alpha1-adrenoceptor blockade by bunazosin in essential hypertension Y. HirataK. FukuiM. Ishii Originals Pages: 575 - 578
Evaluation of the beta-adrenoceptor blocking activity of the Class Ic antiarrhythmic drug diprafenone in man F. WagnerE. JähnchenD. Trenk Originals Pages: 579 - 582
Lidocaine treatment of neonatal convulsions, a therapeutic dilemma A. WallinA. NergårdhP. -Å. Hynning Originals Pages: 583 - 586
Effects of prolonged administration of the angiotensin converting enzyme inhibitor CGS 16617 in normotensive volunteers G. WaeberM. BurnierH. R. Brunner Originals Pages: 587 - 591
Effect of human atrial natriuretic peptide on blood glucose concentrations and hormone stimulation during insulin-induced hypoglycaemia in healthy man E. JungmannC. KonzokK. Schöffling Originals Pages: 593 - 597
Comparison of faecal blood loss, upper gastrointestinal mucosal integrity and symptoms after piroxicam beta-cyclodextrin, piroxicam and placebo administration L. PatoiaG. ClausiL. Bufalino Originals Pages: 599 - 604
The hyperventilation-induced ischaemia model in human neuropharmacology: neurophysiological and psychometric studies of aniracetam and 3-OH aniracetam V. KraaierA. C. van HuffelenG. H. Wieneke Originals Pages: 605 - 611
The pharmacokinetics of ceftriaxone and cefotaxime in cirrhotic patients with ascites L. HaryM. AndrejakJ. P. Capron Originals Pages: 613 - 616
Suppression of histamine-induced skin reactions by loratadine and cetirizine diHCl K. Kontou-FiliG. PaleologosM. Herakleous Originals Pages: 617 - 619
Use of prescription forgeries in a drug abuse surveillance network U. BergmanM. -L. Dahl-Puustinen Originals Pages: 621 - 623
Sustained-release and instant-release verapamil in treatment of angina pectoris C. M. JespersenN. A. KlitgaardJ. Fischer Hansen Short Communications Pages: 625 - 627
Comparison of trimethadione and antipyrine as indicators of oxidative drug metabolizing capacity in man E. TanakaK. Nakamura Short Communications Pages: 629 - 632
Pharmacokinetics and tolerance of a new penem antibiotic, FCE 22101, in healthy volunteers after a single intravenous dose M. G. JannuzzoM. MandelliD. Sassella Short Communications Pages: 633 - 635
Influence of nicardipine on renal function and plasma cyclosporin in renal transplant patients M. KesslerP. NetterB. Dousset Letters To The Editor Pages: 637 - 638
Comparative pharmacokinetics of zidovudine (AZT) and its metabolite (G.AZT) in healthy subjects and HIV seropositive patients E. SinglasJ. C. PiogerJ. P. Fillastre Letters To The Editor Pages: 639 - 640
Use of ranitidine in young infants with gastro-oesophageal reflux E. MalletO. MouterdeN. Moore Letters To The Editor Pages: 641 - 642
